Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms

Affiliations

• ¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
• ² National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
• ³ Division of Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Basel, Switzerland.
• ⁴ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
• ⁵ Division of Hematology, Department of Medicine, University of Washington, Seattle, WA.
• ⁶ Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Washington, Seattle, WA.
• ⁷ Haematology Department, Royal North Shore Hospital, Sydney, NSW, Australia.
• ⁸ Northern Blood Research Centre, Kolling Institute of Medical Research, The University of Sydney, Sydney, Australia.
• ⁹ Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, The University of Sydney, Sydney, NSW, Australia.
• ¹⁰ National Health and Medical Research Council National Centre for Antimicrobial Stewardship at The Peter Doherty Institute for Infections and Immunity, Parkville, VIC, Australia.
• ¹¹ Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
• ¹² Pharmacy Department, Grampians Health, Ballarat, VIC, Australia.
• ¹³ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ¹⁴ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
• ¹⁵ Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA.
• ¹⁶ Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA.
• ¹⁷ Department of Epidemiology, University of Washington, Seattle, WA.